Search company, investor...
AllStripes company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Unattributed VC | Alive

Total Raised


Last Raised

$45.2M | 7 mos ago

Mosaic Score

+40 points in the past 30 days

What is a Mosaic Score?
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

About AllStripes

AllStripes is a San Francisco, California-based healthcare technology company dedicated to accelerating research for patients with rare diseases. AllStripes has developed a technology platform that generates deep data insights to accelerate rare disease research and drug development, as well as a patient application that allows patients and families to get access to and benefit from their own medical data.

AllStripes Headquarters Location

121 2nd Street Suite 700

San Francisco, California, 94105,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing AllStripes

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned AllStripes in 3 CB Insights research briefs, most recently on May 28, 2020.

Expert Collections containing AllStripes

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

AllStripes is included in 5 Expert Collections, including Clinical Trials Tech.


Clinical Trials Tech

329 items

Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.


Digital Health 150

300 items

2019's cohort of the most promising digital health startups transforming the healthcare industry


Digital Health

13,114 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)


Clinical Trials Tech Market Map

108 items

This CB Insights Tech Market Map highlights 100+ clinical trials tech companies that are addressing 8 distinct technology priorities that pharmaceutical companies and CROs face.


Biopharma Tech

326 items

Latest AllStripes News

AllStripes: How this HealthTech Company Leverages Science to Advance Rare Disease Research (Pt. 1 & Pt. 2)

Dec 17, 2021

A two-part interview with AllStripes co-founder Nancy Yu on PatientWorthy went in depth about Yu’s background, why she started the company, and plans for the future. It begins by highlighting her interest in how science and technology interact with one another. Yu explained how growing... The post AllStripes: How this HealthTech Company Leverages Science to Advance Rare Disease Research (Pt. 1 & Pt. 2) appeared first on McKesson Ventures.

AllStripes Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

AllStripes Rank

  • When was AllStripes founded?

    AllStripes was founded in 2017.

  • Where is AllStripes's headquarters?

    AllStripes's headquarters is located at 121 2nd Street, San Francisco.

  • What is AllStripes's latest funding round?

    AllStripes's latest funding round is Unattributed VC.

  • How much did AllStripes raise?

    AllStripes raised a total of $115M.

  • Who are the investors of AllStripes?

    Investors of AllStripes include Lux Capital, Spark Capital, Jazz Venture Partners, Maveron, Medidata Solutions and 9 more.

  • Who are AllStripes's competitors?

    Competitors of AllStripes include Syapse, Owkin,, ConcertAI, TrialJectory, Verana Health, Holmusk, Ciitizen, Verantos, Aetion and 14 more.

You May Also Like


Verantos specializes in high accuracy real-world evidence (RWE) generation. The Verantos RWE platform integrates heterogeneous real-world data sources and generates evidence with the accuracy necessary for regulatory and reimbursement use. The Verantos RWE platform leverages data science and artificial intelligence along with advanced data sources to generate RWE capable of supporting clinical assertions.

Syapse Logo

Syapse develops applications that enable the use of omics profiles in diagnosing and treating patients at diagnostic companies, research institutions, medical centers, and payers. The Syapse Discovery application provides an end-to-end solution for companies and laboratories deploying sequencing-based diagnostics, from patient sample received to physician report delivered. Discovery's configurable semantic data structure enables users to bring omics data together with traditional medical information to develop and deliver diagnostic tests. The platform's open interfaces enable bioinformaticians and biologists to use their favorite computational tools and annotations. The company was formerly known as BDLicense. Syapse was founded in 2008 and is based in San Francisco, California.

Ignite Data Logo
Ignite Data

Ignite Data helps access the right patients and data for UK clinical studies and database projects.

Validic Logo

Motivation Science is the developer of Validic, a digital health platform that provides a simple connection to secure, standardized data from specialized digital health technologies, such as wellness applications, wearables, fitness equipment and clinical devices.

Datavant Logo

Datavant is dedicated to accelerating the discovery, development, and commercialization of new medicines through machine learning. It aims to partner with biomedical research institutions to eliminate silos of information and unlock insights from healthcare data. The firm was founded in 2017 and is based in San Francisco, California.

Owkin Logo

Owkin specializes in AI technologies applied to clinical research with the aim of developing better drugs and treatments for patients. The company's purpose is to empower researchers in hospitals, universities and the biopharma industry to i) understand why drug efficacy varies from patient to patient, ii) improve the drug development process and iii) to help identify key drugs and treatments for each individual patient to improve patient outcomes. The company's precision medicine platform aims to enable medical insights for drug discovery and development by connecting life sciences firms with academic researchers and hospitals. The Owkin platform aims to enable partners to uncover siloed datasets while maintaining patient privacy and securing proprietary data using Federated Learning and innovative collaborative AI technology. The company was founded in 2016 and is based in New York, New York.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.